Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
Br J Ophthalmol ; 91(1): 33-6, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16916876

ABSTRACT

AIM: To identify and quantify the prevalence of patients with uveitis receiving systemic immunosuppression in Scotland. METHODS: Anonymised data were prospectively collected on all patients with uveitis requiring systemic immunosuppression. Seven health boards participated over a 4-month period between 1 August 2005 and 30 November 2005. RESULTS: 373 patients were identified, of whom 205 (55%) were female. The mean age was 46.4 (range 7-97 years). Using the data from the seven participating health boards, an estimated Scottish prevalence of 9 per 100 000 was calculated. Prevalence varied between 2 and 59 per 100 000. In National Health Service Grampian, all patients with uveitis, whether sight-threatening or not, are followed up at a specialist clinic. Extrapolating this figure to Scotland gives a prevalence of 25 per 100 000. DISCUSSION: The data from National Health Service Grampian suggest that there is a significant shortfall in the number of patients identified by survey. If the "missing population" exists, then where are they? Some might be receiving appropriate treatment at non-specialist clinics, although simple under-reporting may play a part. Greater concern is for those patients receiving inappropriate treatment for their uveitis, or for those within the community who are either oblivious to or in self denial of their condition.


Subject(s)
Immunosuppression Therapy , Uveitis/epidemiology , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Blindness/etiology , Child , Female , Humans , Male , Middle Aged , Prevalence , Prospective Studies , Scotland/epidemiology , Sex Distribution , Uveitis/complications , Uveitis/immunology
3.
Ophthalmic Physiol Opt ; 19(5): 365-75, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10768018

ABSTRACT

The disc-macula distance to disc diameter ratio (DM:DD ratio) has been advocated as a method of supporting the diagnosis of optic nerve hypoplasia. A DM:DD ratio of 3.00 has been claimed to be a satisfactory threshold value for this purpose. This study has critically evaluated the above claim and found a value of 3.00 to be too low. The threshold DM:DD ratio values for the diagnosis of unequivocal ONH for an adult population, 5 and 2 years of age were found to be respectively 4.20, 3.93 and 3.70, the values for the diagnosis of mild ONH being 3.68, 3.44 and 3.23. Lower computed values reduce the predictive power. The method of computation of the DM:DD ratio was modified to abolish potential error due to disc rotation and foveal displacement. In an adult population, there was no correlation between the DM:DD ratio and amblyopia or disc ovalness. There was a trend of increasing DM:DD ratio towards myopia and decreasing DM:DD ratio towards hypermetropia; the DM:DD ratio may therefore be falsely high in high myopia. DM:DD ratio values below threshold should therefore be interpreted with care until formal optic disc biometry can be performed.


Subject(s)
Fluorescein Angiography , Optic Disk/anatomy & histology , Optic Nerve Diseases/diagnosis , Adolescent , Adult , Biometry/methods , Female , Fovea Centralis/anatomy & histology , Humans , Male , Middle Aged , Reproducibility of Results
6.
Am J Pathol ; 140(6): 1473-82, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1351369

ABSTRACT

Thrombospondin (TSP), which plays an important hemostatic role, is a 450-kd cytoadhesive protein present in the alpha granules of platelets. In vitro experiments using cultured malignant cells suggest that it may help to mediate malignant cell attachment to extracellular matrix and may be important in cancer invasiveness. The authors studied a group of malignant and benign breast tissues for the expression of TSP and provide evidence that TSP may have a role in tumor invasiveness. Using immunohistochemical techniques, the authors found in 48 fresh specimens of breast carcinoma that TSP stained strongly in the desmoplastic stroma or at the basement membrane associated with the malignant ductal epithelium. Tumor cells abutting these tissues revealed cytoplasmic staining for TSP. Stronger TSP staining was seen in the poorly differentiated tumors. These findings were compared with those of normal and benign breast tissue, which showed no TSP staining apart from reactivity in the large distended cysts of fibrocystic disease and faint staining in the stroma of fibroadenomas. Staining for integrin was positive in lymphocytes of both malignant and benign breast disease and equivocally also in the stromal cells of the breast cancer tissue. Immunoreactivity to TSP in tissues was also compared with that of fibronectin, laminin, and collagen type I, III, and IV. The overall findings suggest that thrombospondin may have a role in the tumor biology of invasiveness.


Subject(s)
Breast Diseases/metabolism , Breast Neoplasms/metabolism , Carcinoma/metabolism , Extracellular Matrix Proteins/metabolism , Platelet Membrane Glycoproteins/metabolism , Adult , Aged , Aged, 80 and over , Antigens, CD/analysis , Breast Diseases/immunology , Breast Neoplasms/immunology , CD18 Antigens , Carcinoma/immunology , Collagen/classification , Collagen/metabolism , Fibronectins/metabolism , Humans , Immunohistochemistry , Laminin/metabolism , Lymphocyte Function-Associated Antigen-1/analysis , Middle Aged , Thrombospondins
7.
Eye (Lond) ; 6 ( Pt 6): 643-7, 1992.
Article in English | MEDLINE | ID: mdl-1289145

ABSTRACT

We studied the surface expression of activation markers IL2-R, HLA-DR and CD45-RO on peripheral T-lymphocytes in two groups of patients (n = 26) with idiopathic uveoretinitis, compared with controls. Thirteen patients were analysed by alkaline phosphatase anti-alkaline phosphatase (APAAP) immunocytochemistry, which demonstrated a significant rise in expression of HLA-DR and IL2-R surface markers. Flow cytometric analysis was performed on a further 13 patients, which confirmed a significant rise in IL2-R expression in uveitis patients. Within this group systemic activation was confined to patients with idiopathic retinal vasculitis. Dual flow cytometry confirmed a CD4+,IL2--R+ T--lymphocyte phenotype. A further 4 patients with retinal vasculitis who had been treated with cyclosporin A demonstrated a 32% reduction in IL2-R expression over a 3-month period. Analysis of CD45-RO and CD5+ cells was found to be uninformative in this study. We have demonstrated activated peripheral lymphocytes in patients predominantly with retinal vasculitis, the significance of which is discussed.


Subject(s)
Lymphocyte Activation/immunology , T-Lymphocytes/immunology , Uveitis, Posterior/immunology , Biomarkers/analysis , Cyclosporine/therapeutic use , Flow Cytometry , HLA-DR Antigens/analysis , Humans , Immunoenzyme Techniques , Leukocyte Common Antigens/analysis , Receptors, Interleukin-2/analysis , Retinal Vessels , Retinitis/drug therapy , Retinitis/immunology
SELECTION OF CITATIONS
SEARCH DETAIL